1. Home
  2. Press release
Jul 29, 2020 15:18 JST

CMB International Securities Maintains High Conviction "BUY" Rating on VPower Group

HONG KONG, Jul 29, 2020 - (ACN Newswire) - CMB International Securities today issued a research report on Hong Kong listed VPower Group International Holdings Limited ("VPower Group", stock code:1608), a leading distributed power generation station owner and operator in Asia with a focus on its investment in the liquefied natural gas (LNG) to power in Myanmar. The firm maintained a high conviction "BUY" rating on VPower Group with a target price of HK$5.47, representing a potential growth of 82.9% as compared to last closing price.

CMB International Securities placed its key focus on VPower Group's iconic Myanmar joint venture and expected it will generate more than 20% internal rate of return, with superior profitability comparing with its other IBO (Investment, Building and Operating) projects.

In addition, CMB International Securities mentioned the LNG cost, utilization rate, and the energy efficiency of the gensets as the key exposures that the joint venture could manage for higher profitability. Yet, the firm believes it is a good timing for VPower Group to expand into LNG-fueled distributed power projects, with the Asia LNG spot market is currently at a range of 3-year low.

CMB International Securities is confident that VPower Group will deliver high earrings growth in FY20/21E, with net profit expected to reach HK$711 million and HK$1,169 million respectively.

Headquartered in Hong Kong, VPower Group is an integrated expert in distributed power generation (DPG). It principally engages in power system integration (SI) business, covering designing, integrating and sale of gas-fired and diesel-fired engine-based gen-sets and power generation systems, and Investment, Building and Operating (IBO) business, involving investing in, building and operating distributed power stations to supply reliable electricity. It is now a leading distributed power station owner and operator in Asia.




Sectors: Daily Finance, Energy, Alternatives, Daily News

Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Latest Press Release


HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST

Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST

MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works
Dec 08, 2025 17:00 JST

Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
Dec 08, 2025 16:34 JST

MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary
Dec 08, 2025 16:03 JST

Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST

TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST

TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST

World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST

Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST

Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST

NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST

The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST

New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST

Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST

Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST

Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST

NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST

Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
 More Latest Release >>